|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 4.000 USD | -5.66% |
|
-2.68% | -26.85% |
| 08-11 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BOLT | Delayed | |
CBOE
| Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 4.285 | 5.39 | 4.67 |
| Spread/Res. | -6.65% | -25.79% | -14.35% |
| Spread/Supp. | +7.82% | +25.89% | +19.40% |
| Support | 3.71 | 3.177 | 3.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BOLT Stock
- Charts Bolt Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
